Prophylactic Biliary Stenting Before Cholecystectomy: Benefit or Harm After Complete Clearance of Common Bile Duct Stones?

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20260130001

Enrollment

102

Registered

2026-01-30

Start date

2020-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with gallstones and common bile duct (CBD) stones after complete CBD stone clearance, focusing on biliary complications occurring while awaiting cholecystectomy, including recurrent CBD stones, acute cholangitis, acute cholecystitis, and gallstone pancreatitis. Choledocholithiasis Gallstones Biliary Stents Endoscopic Retrograde Cholangiopancreatography (ERCP)

Interventions

Patients who received prophylactic biliary stent placement after complete clearance of common bile duct stones and before cholecystectomy.,Patients who did not receive biliary stent placement after co

Treatment,Treatment

Stent group,Non stent group

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age 18 years or older 2.Patients who underwent ERCP with complete clearance of common bile duct stones 3.Patients who subsequently underwent cholecystectomy 4.Treatment performed at HRH Princess Maha Chakri Sirindhorn Medical Center, Srinakharinwirot University 5.Treatment period between 1 January 2020 and 31 December 2024

Exclusion criteria

Exclusion criteria: 1.Incomplete clearance of common bile duct stones after ERCP 2.Biliary stenting performed for other indications (e.g., biliary stricture or cholangiocarcinoma) 3.Patients without gallbladder stones 4.Biliary stent placement used as treatment for acute cholangitis rather than prophylaxis

Design outcomes

Primary

Measure	Time frame
- - -,Acute cholangitis, acute cholecystitis, gallstone pancreatitis, recurrent CBD stone date of index ERCP where CBD stones were documented as completely cleared to date of laparoscopic cholecystectomy (LC) Cumulative incidence	—

Secondary

Measure	Time frame
- - -,independent variables: baseline/procedure factors (age, CBD diameter, stone size/number, comorbidities, frailty, ERCP techniques, waiting time, stent type, etc.) date of index ERCP where CBD stones were documented as completely cleared to date of laparoscopic cholecystectomy (LC) Logistic regression (simple)	—

Countries

Thailand

Contacts

Public ContactWorarit Cheawchansin

Srinakharinwirot University

suiworarit@gmail.com0892047004

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026